Urgent Call to Action: Integrating Chronic Liver Disease into European Health Policy
Chronic liver disease (CLD) remains a significant public health challenge across Europe, with the latest Lancet Regional Health – Europe Series highlighting the urgent need for systemic policy changes. Led by researchers from the Barcelona Institute for Global Health (ISGlobal), the series underscores that current national and EU-level strategies fail to address the growing human and economic burden of CLD, advocating for its integration into broader health frameworks.
The Burden of Chronic Liver Disease in Europe
CLD, encompassing conditions such as hepatitis, cirrhosis and fatty liver disease, is a leading cause of mortality and disability across Europe. The Lancet series emphasizes that the disease imposes a “very high human and economic burden,” with rising prevalence linked to factors like alcohol consumption, obesity, and viral hepatitis. Despite these challenges, the authors note that European countries have not prioritized CLD in national health agendas or EU-wide policy initiatives.
“The lack of coordinated action is alarming,” says Jeffrey V. Lazarus, lead author of the series. “Without embedding CLD within broader public health strategies, the region risks exacerbating health inequities and economic strain.”
Policy Gaps and the Need for Systemic Change
The report identifies critical gaps in current approaches, including insufficient funding for research, fragmented healthcare services, and limited public awareness. It calls for a paradigm shift, urging governments and EU institutions to treat CLD as a priority within existing frameworks such as the European Health Union and the Sustainable Development Goals.
Key recommendations include:
- Establishing national CLD action plans with measurable targets.
- Increasing investment in prevention programs, particularly for viral hepatitis and alcohol-related liver disease.
- Enhancing cross-border collaboration to share best practices, and resources.
Expert Perspectives and Next Steps
The series also highlights the role of healthcare professionals in advocating for policy reforms. Elisa Pose, a liver specialist at Hospital Clinic of Barcelona, stresses the importance of “integrating liver health into primary care and public health campaigns.” Paul Brennan, a researcher at the University of Dundee, adds that “innovative policies are needed to tackle the root causes, such as public health campaigns and stricter regulations on alcohol and unhealthy diets.”
The authors conclude that addressing CLD requires a multi-sectoral approach, involving governments, healthcare systems, and civil society. “This is not just a medical issue but a societal one,” Lazarus asserts. “Only through systemic change can Europe mitigate the rising toll of chronic liver disease.”
Key Takeaways
- Chronic liver disease is a major public health threat in Europe, with significant human and economic costs.
- Current policies fail to prioritize CLD, leading to fragmented responses and inadequate resources.
- The Lancet series urges integration of CLD into national and EU health frameworks, emphasizing prevention and collaboration.
- Experts call for targeted investments, public awareness campaigns, and cross-border cooperation to address the crisis.
As the Lancet series makes clear, the time for action is now. Without urgent policy reforms, the growing burden of chronic liver disease will continue to strain healthcare systems and jeopardize public health across Europe.